19^th World Congress on Biomarkers, Cancer Therapy & Clinical Research October 30-31, 2024 Rome, Italy

Dr. Ramona D’Amico has completed master's degree in biology at the University of Messina in 2016. Dr. Ramona D’Amico has completed her PhD in Applied Biology and Experimental Medicine in the year 2020 by University of Messina. Additionally, she worked at Health Science Research Centre, Whiteland College, University of Roehampton in London (UK) and performed postdoctoral studies at University of Messina. She worked as researcher for studies on preclinical biochemical and pharmacology activities (in vitro primary cultures and in vivo experimental models), for the Epitech Group; she is also a research fellow in Biochemistry at Messina University. Now she is a Researcher in Clinical Biochemistry at the University of Messina. She has published more than 100 articles in reputed journals about biomarkers, molecular pathways, oxidative stress, inflammation and natural compound. Her research is involved in preclinical studies for the discovery of new biomarkers. Dr. Ramona D’Amico have knowledge about animals research, biochemical and molecular biology, immunohistochemical and immunofluorescence analysis.

Health Science Research

Master's degree in Biological Sciences, PhD in "Experimental Medicine", Associate Professor in Clinical Biochemistry and Clinical Molecular Biology at Messina University, Dpt of Chemical, Biological, Pharmaceutical and Environmental Sciences. She has an important research background in the fields of inflammation, neuroinflammation, oxidative stress, pain, immunity in specific area of biochemistry, pharmacology and neuroscience and nutrition

biochemistry, pharmacology, nutrition

Dr. Luo is a member of the Divisions of Experimental Pathology, Molecular and Cellular Pathology and Anatomic Molecular Pathology. He is the Director of the High Throughput Genome Center at the Department of Pathology, University of Pittsburgh, involving collaboration of faculties from multiple departments. Dr. Luo been studying molecular pathology related to human malignancies in the last 23 years. Currently, he is a Professor of Pathology and Director of High Throughput Genome Center at University of Pittsburgh. In the last 13 years, Dr. Luo has been largely focusing on genetic and molecular mechanism of human prostate and hepatocellular carcinomas.

Reacher

Youhe Gao Professor Beijing Normal University. He received his MD from Peking Union Medical College, his Ph.D from University of Connecticut and postdoctoral training from Beth Israel Deaconess Medical Center, Harvard Medical School. He was the professor of Department of Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/ Peking Union Medical College from 2001-2014. His research interests include biomarker discovery in urine, urine biobanking, protein interaction methods and related bioinformatics.

Reacher